Jamil El-Ali

Jamil El-Ali currently serves as the Associate Vice President of Enterprise Strategy at Agilent Technologies, a position held since 2012, where responsibilities include corporate strategy development and planning in collaboration with CEO staff. Jamil has previously held roles such as AVP of Commercial CDx Pharma programs in the Diagnostics & Genomics Group, where oversight included global market development for PD-L1 CDx programs, and Senior Director of clinical and diagnostic segment marketing. Prior to Agilent, Jamil was the Vice President of Corporate Strategy & Planning at Dako and held positions at McKinsey & Company and the Massachusetts Institute of Technology as a consultant and postdoctoral associate, respectively. Jamil holds a Ph.D. in Microtechnology and an M.Sc. in Applied Physics from the Technical University of Denmark.